Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

Diabetes researchers have named one major diet swap that helps reduce blood sugar levels and your risk of developing heart ...

Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Anti-inflammatory drugs were linked to a reduced risk of dementia. Antibiotics, antivirals and vaccines, such as for ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

The research has attracted international attention – a number of foreign hospitals and facilities have been in touch with the ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.